Sorrento TherapeuticsSRNE
13F holders, Q1 2024 (March 31)7holders
$0.01avg. 13F price*
At the end of Q1 2024, 7 institutions reported holding Sorrento Therapeutics Inc. (SRNE) in their 13F filings. The largest holders were Lattice Capital Management, LLC ($414), KLCM Advisors, Inc. ($240) and Huntington National Bank ($40).
- Company
- Sorrento Therapeutics Inc.
- CUSIP
- 83587F202
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 2 | $25 |
Ownership 7 holders
| Lattice Capital Management, LLC | 0.00% | No change | 51,800 | $414 |
| KLCM Advisors, Inc. | 0.00% | No change | 30,000 | $240 |
| Huntington National Bank | 0.00% | No change | 5,001 | $40 |
| Highlander Capital Management, LLC | 0.00% | No change | 1,200 | $10 |
| AlphaMark Advisors, LLC | 0.00% | No change | 2,135 | $0 |
| HighPoint Advisor Group LLC | 0.00% | No change | 22,250 | $0 |
| SlateStone Wealth, LLC | 0.00% | No change | 21,433 | $0 |
"% of holder's portfolio" is SRNE's weight in each manager's 13F, not the share of Sorrento Therapeutics Inc. the manager owns.